Viatris, Inc. (VTRS)
15.77
-0.02
(-0.13%)
USD |
NASDAQ |
Feb 13, 16:00
15.70
-0.07
(-0.44%)
After-Hours: 20:00
Viatris Cash from Investing (Quarterly) : -98.90M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Boston Scientific Corp. | -- |
| Baxter International, Inc. | -111.00M |
| Intuitive Surgical, Inc. | -209.40M |
| West Pharmaceutical Services, Inc. | -63.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 744.90M |
| Cash from Financing (Quarterly) | -228.10M |
| Free Cash Flow | 1.614B |
| Free Cash Flow Per Share (Quarterly) | 0.554 |
| Free Cash Flow to Equity (Quarterly) | 688.30M |
| Free Cash Flow to Firm (Quarterly) | 2.610B |
| Free Cash Flow Yield | 8.67% |